Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Intranasal administration of a stapled relaxin‐3 mimetic has anxiolytic‐ and antidepressant‐like activity in rats
Subhi Marwari, Anders Poulsen, Norrapat Shih, et al.
British Journal of Pharmacology (2019) Vol. 176, Iss. 20, pp. 3899-3923
Open Access | Times Cited: 18

Showing 18 citing articles:

Therapeutic stapled peptides: Efficacy and molecular targets
Yulei Li, Ming‐Hao Wu, Yinxue Fu, et al.
Pharmacological Research (2024) Vol. 203, pp. 107137-107137
Open Access | Times Cited: 12
Miniproteins as a Powerful Modality in Drug Development
Zachary R. Crook, Natalie W. Nairn, James M. Olson
Trends in Biochemical Sciences (2020) Vol. 45, Iss. 4, pp. 332-346
Open Access | Times Cited: 67
Anxiety and Depression: What Do We Know of Neuropeptides?
Ida Kupcová, Ľuboš Danišovič, Ivan Grgac, et al.
Behavioral Sciences (2022) Vol. 12, Iss. 8, pp. 262-262
Open Access | Times Cited: 37
Advances and Challenges in Intranasal Delivery of Antipsychotic Agents Targeting the Central Nervous System
Manisha Pandey, Neha Jain, Jovita Kanoujia, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 17
Mechanisms of biased agonism by Gα i/o -biased stapled peptide agonists of the relaxin-3 receptor
Tharindunee Jayakody, Asuka Inoue, Srinivasaraghavan Kannan, et al.
Science Signaling (2024) Vol. 17, Iss. 823
Closed Access | Times Cited: 3
Novel RXFP3 negative allosteric modulator RLX‐33 reduces alcohol self‐administration in rats
Kalynn J. Van Voorhies, Wen Liu, Dennis F. Lovelock, et al.
Journal of Neurochemistry (2023) Vol. 167, Iss. 2, pp. 204-217
Open Access | Times Cited: 6
The putative role of the relaxin-3/RXFP3 system in clinical depression and anxiety: A systematic literature review
Win Lee Edwin Wong, Gavin S. Dawe, Allan H. Young
Neuroscience & Biobehavioral Reviews (2021) Vol. 131, pp. 429-450
Open Access | Times Cited: 10
Development of Relaxin-3 Agonists and Antagonists Based on Grafted Disulfide-Stabilized Scaffolds
Han Siean Lee, M. M. Postan, Angela Song, et al.
Frontiers in Chemistry (2020) Vol. 8
Open Access | Times Cited: 7
Indole-Containing Amidinohydrazones as Nonpeptide, Dual RXFP3/4 Agonists: Synthesis, Structure–Activity Relationship, and Molecular Modeling Studies
Dongliang Guan, Md Toufiqur Rahman, Elaine A. Gay, et al.
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 24, pp. 17866-17886
Open Access | Times Cited: 6
Regulatory peptides and systems biology: A new era of translational and reverse‐translational neuroendocrinology
Lee E. Eiden, Andrew L. Gundlach, Valery Grinevich, et al.
Journal of Neuroendocrinology (2020) Vol. 32, Iss. 5
Open Access | Times Cited: 5
Neural Receptors Associated with Depression: A Systematic Review of the Past 10 Years
Alice Barros Câmara, Igor Augusto Brandão
CNS & Neurological Disorders - Drug Targets (2020) Vol. 19, Iss. 6, pp. 417-436
Closed Access | Times Cited: 4
Relaxin family peptide receptor 3 (RXFP3) expressing cells in the zona incerta/lateral hypothalamus augment behavioural arousal
B. Richards, Sarah S. Ch’ng, Ariel B Simon, et al.
Journal of Neurochemistry (2024)
Open Access
Stapled peptides as potential therapeutics for diabetes and other metabolic diseases
Dominika Nielipińska, Dominika Rubiak, Agnieszka J Pietrzyk-Brzezińska, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 180, pp. 117496-117496
Open Access
Hydrophobic interactions of relaxin family peptide receptor 3 with ligands identified using a NanoBiT-based binding assay
Hao‐Zheng Li, Ning Li, Xiao‐Xia Shao, et al.
Biochimie (2020) Vol. 177, pp. 117-126
Closed Access | Times Cited: 3
Exploring the Use of Helicogenic Amino Acids for Optimising Single Chain Relaxin-3 Peptide Agonists
Han Siean Lee, Shu Hui Wang, James T. Daniel, et al.
Biomedicines (2020) Vol. 8, Iss. 10, pp. 415-415
Open Access | Times Cited: 3
Relaxin family peptide receptors in GtoPdb v.2021.3
Ross A. D. Bathgate, Thomas Dschietzig, Andrew L. Gundlach, et al.
IUPHAR/BPS Guide to Pharmacology CITE (2021) Vol. 2021, Iss. 3
Open Access | Times Cited: 2
Patent Highlights April–May 2019
Hermann AM Mucke
Pharmaceutical Patent Analyst (2019) Vol. 8, Iss. 5, pp. 165-173
Open Access | Times Cited: 1
Relaxin family peptide receptors in GtoPdb v.2023.1
Alexander I. Agoulnik, Ross A. D. Bathgate, Thomas Dschietzig, et al.
IUPHAR/BPS Guide to Pharmacology CITE (2023) Vol. 2023, Iss. 1
Open Access
Page 1

Scroll to top